They raise and lower the risk for different reasons, at different times STUDY: Xie Y et al, BMJ Medicine 2026 STUDY TYPE: Cohort study (target trial emulation) FUNDING: US Department of Veterans Affairs Background Pancreatitis is a rare side effect of GLP-1 receptor agonists
Developed to treat symptoms of type 2 diabetes, Ozempic (semaglutide) was licensed for medical use in 2017 by Novo Nordisk
Effect of omega-3 fatty acid plus vitamin e Co-supplementation on oxidative stress parameters: A systematic review and meta-analysis
Successful weight loss depends not only on choosing the right medication, but also on choosing the right patient, the right dose, and providing regular follow-up. Dr
(Being so short-lived in your system is part of what gives it such a good safety record.) Dr
People using GLP-1s may be less likely to need new preventive migraine medications